April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Effect of Cholinergic Drugs on Optic Nerve Structure and Function in Glaucoma
Author Affiliations & Notes
  • Helga Kecova
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Elena Hernandez-Merino
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Samantha J. Jacobson
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Adam C. Crumpton
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Meaghan E. Pryde
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Karl N. Hamouche
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Randy H. Kardon
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
    Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa
  • Matthew M. Harper
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Sinisa D. Grozdanic
    Veterinary Clinical Sciences, Iowa State University, Ames, Iowa
    Center of Excellence for Prevention and Treatment of Vision Loss, Veterans Administration, Iowa City, Iowa
  • Footnotes
    Commercial Relationships  Helga Kecova, None; Elena Hernandez-Merino, None; Samantha J. Jacobson, None; Adam C. Crumpton, None; Meaghan E. Pryde, None; Karl N. Hamouche, None; Randy H. Kardon, None; Matthew M. Harper, None; Sinisa D. Grozdanic, None
  • Footnotes
    Support  Veterans Administration RR & D, Grant number: 1 I01 RX000171-01A1
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2464. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Helga Kecova, Elena Hernandez-Merino, Samantha J. Jacobson, Adam C. Crumpton, Meaghan E. Pryde, Karl N. Hamouche, Randy H. Kardon, Matthew M. Harper, Sinisa D. Grozdanic; Effect of Cholinergic Drugs on Optic Nerve Structure and Function in Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2464.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To characterize effects of topical (demecarium bromide-DB) and systemic (citicoline-citi) cholinergic drugs on optic nerve (ON) function and structure in canine model of primary glaucoma.

Methods: : Nerve fiber layer (NFL) thickness was evaluated by optical coherence tomography (OCT) in healthy (HB) and glaucomatous (GB) Bassets. Diameter of retinal vessels (on OCT scans) and ON function (recorded using pattern electroretinography - pERG) was evaluated in GB before and after cholinergic therapy (DB and citi). GB treated with cholinergic drugs and non-treated GB were subjected to provocative test of ON function by acute elevation of intraocular pressure with concurrent pERG recording.

Results: : OCT analysis showed early thickening of NFL in glaucomatous dogs. Topical DB and systemic citicoline did not have significant effect on NFL thickness (p>0.5, Paired t-test), but caused significant vasodilatation of retinal blood vessels (DB: p=0.046, citi: p<0.0001, Paired t-test). Baseline pERG amplitudes significantly improved in DB treated dogs (before treatment = 3.6+0.3µV; post treatment = 4+0.4µV; p=0.0004, Paired t-test) but not in citi treated dogs. However, both DB and citi had significant protective effect on ON function during acute IOP stress challenge: at IOP of 50 mmHg, pERG amplitude was 0.5 + 0.17µV in non-treated GB, 0.98 + 0.3µV in DB-treated GB (p=0.0245, Unpaired t-test) and 1.83 + 0.24µV in citi-treated GB (p=0.0003, Unpaired t-test).

Conclusions: : Early changes in glaucomatous canine eyes are characterized by structural (NFL thickening) and functional (pERG deficits) changes. Topical and systemic cholinergic drugs reversed functional optic nerve deficits and/or significantly improved optic nerve resistance to acute IOP stress. Both citi and DB caused dilation of retinal vasculature. Cholinergic agents should be considered as possible neuroprotective therapeutic agents for treatment of glaucoma.

Keywords: intraocular pressure • electroretinography: clinical • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×